| 查看: 2878 | 回复: 29 | |||
| 当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖 | |||
qianye2008银虫 (正式写手)
|
[交流]
一审结束,大家帮忙看看主编是啥意思 已有21人参与
|
||
|
The Editors of Journal of Chemical Technology & Biotechnology thank you for submitting this paper but regret to advise you that it is not acceptable for publication in its present form, and will require substantial revision before it could be considered for publication. The Editors however, would be happy to consider a rewritten and resubmitted paper. You will need to submit your revision using our online system at the following link: https://mc.manuscriptcentral.com/jctb-wiley and provide a final copy of your manuscript - highlighting any changes to the text in red - as well as providing a point-by-point list of your responses to the reviewers' and Editor's comments. Please make sure that the list clearly states where you have made changes to your manuscript. Remember to: • include the 200 word compound abstract (with Background, Results and Conclusion subheadings) if your article is an original research paper • carefully proof-read the manuscript to minimize typographical, grammatical and bibliographical errors. • use the Vancouver style for references. Indicate citations at the appropriate place in the text using superscript numbers in the strict order in which they appear, and then give a full numerical list at the end of the paper. There are also some simple steps that you can follow to make your article more discoverable online. Click on this link to find out more: https://www.wiley.com/legacy/wil ... AuthorsLINKSrev.pdf If possible, please revise your manuscript within four weeks of receipt of this letter. If you expect revisions to take longer than this, please let us know when you expect to submit a revised manuscript. When you are ready to submit the revised version of the manuscript, please log into your “Author Center”, click on the 'manuscripts with decision' queue and follow the link to create a revision. You will be able to view the comments on your manuscript and submit the revised version. If you are unsure of your account access details, you can retrieve it by clicking on the “Check for Existing Account” link. 拒搞还是大修呢?希望大不大 发自小木虫Android客户端 [ Last edited by qianye2008 on 2018-8-5 at 08:48 ] |
» 猜你喜欢
北京211副教授,35岁,想重新出发,去国外做博后,怎么样?
已经有7人回复
Cas 72-43-5需要30g,定制合成,能接单的留言
已经有7人回复
磺酰氟产物,毕不了业了!
已经有5人回复
论文终于录用啦!满足毕业条件了
已经有25人回复
2026年机械制造与材料应用国际会议 (ICMMMA 2026)
已经有3人回复
自荐读博
已经有3人回复
求助:我三月中下旬出站,青基依托单位怎么办?
已经有5人回复
不自信的我
已经有5人回复
投稿Elsevier的杂志(返修),总是在选择OA和subscription界面被踢皮球
已经有8人回复

luckydogzhang
至尊木虫 (著名写手)
闲散人
- SEPI: 3
- 应助: 14 (小学生)
- 金币: 20642.8
- 散金: 110
- 红花: 59
- 帖子: 1989
- 在线: 283.5小时
- 虫号: 93958
- 注册: 2005-09-25
- 专业: 生物医用高分子材料

9楼2018-08-05 00:14:10









回复此楼